Revolution Medicines’ Cislini Sells Shares Amid FDA Breakthrough; Investor Watch Needed
Jeff Cislini’s insider sale at Revolution Medicines: what it means for investors, daraxonrasib milestones, and market sentiment.
3 minutes to read
REVOLUTION MEDICINES INC
Revolution Medicines Insider Sales: Routine Vesting, Not a Confidence Signal
Insider sales at Revolution Medicines are routine RSU vesting, not a confidence signal—market remains flat, investors should watch future filings for clues.
4 minutes to read
Insider Kelsey Stephen Michael Sells 10M Shares of Revolution Medicines, Cutting 32% Stake
Insider Kelsey Stephen Michael sells 10M+ shares of Revolution Medicines at premium, cutting stake 32% yet keeping long‑term confidence—watch the impact on the stock.
4 minutes to read